BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 27176479)

  • 21. An Inverse U-Shaped Curve of Resting-State Networks in Individuals at High Risk of Alzheimer's Disease.
    Ye Q; Chen H; Su F; Shu H; Gong L; Xie C; Zhou H; Bai F
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29474008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.
    Wang X; Wang J; He Y; Li H; Yuan H; Evans A; Yu X; He Y; Wang H
    J Alzheimers Dis; 2015; 45(3):781-95. PubMed ID: 25624419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.
    Pyun JM; Park YH; Lee KJ; Kim S; Saykin AJ; Nho K;
    Transl Neurodegener; 2021 Aug; 10(1):32. PubMed ID: 34465370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction of APOE genotype by age in amnestic mild cognitive impairment: a voxel-based morphometric study.
    Chen J; Shu H; Wang Z; Liu D; Shi Y; Zhang X; Zhang Z
    J Alzheimers Dis; 2015; 43(2):657-68. PubMed ID: 25114090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The apolipoprotein E gene affects the three-year trajectories of compensatory neural processes in the left-lateralized hippocampal network.
    Ye Q; Su F; Shu H; Gong L; Xie C; Zhang Z; Bai F
    Brain Imaging Behav; 2017 Oct; 11(5):1446-1458. PubMed ID: 27734307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential impact of ApoE ε4 on cortical activation during famous face recognition in cognitively intact individuals and patients with amnestic mild cognitive impairment.
    Frank G; Hennig-Fast K; Klünemann HH; Schmitz G; Greenlee MW
    Alzheimer Dis Assoc Disord; 2011; 25(3):250-61. PubMed ID: 21192235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the NIH Toolbox Odor Identification Test across normal cognition, amnestic mild cognitive impairment, and dementia due to Alzheimer's disease.
    Echevarria-Cooper SL; Ho EH; Gershon RC; Weintraub S; Kahnt T
    Alzheimers Dement; 2024 Jan; 20(1):288-300. PubMed ID: 37603693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of hippocampal volume and serum brain-derived neurotrophic factor as potential diagnostic markers of conversion from amnestic mild cognitive impairment to Alzheimer disease: A STROBE-compliant article.
    Fang Y; Du N; Xing L; Duo Y; Zheng L
    Medicine (Baltimore); 2019 Jul; 98(30):e16604. PubMed ID: 31348306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Features of a modified WHO/UCLA AVLT performance in amnestic mild cognitive impairment and mild Alzheimer's disease].
    Jin HM; Li D; Yu YY; Zhang M; Liu XN; Li FY; Wu LY; Wang F
    Zhonghua Yi Xue Za Zhi; 2019 Aug; 99(31):2423-2428. PubMed ID: 31434421
    [No Abstract]   [Full Text] [Related]  

  • 30. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
    Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
    Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study.
    Ten Kate M; Redolfi A; Peira E; Bos I; Vos SJ; Vandenberghe R; Gabel S; Schaeverbeke J; Scheltens P; Blin O; Richardson JC; Bordet R; Wallin A; Eckerstrom C; Molinuevo JL; Engelborghs S; Van Broeckhoven C; Martinez-Lage P; Popp J; Tsolaki M; Verhey FRJ; Baird AL; Legido-Quigley C; Bertram L; Dobricic V; Zetterberg H; Lovestone S; Streffer J; Bianchetti S; Novak GP; Revillard J; Gordon MF; Xie Z; Wottschel V; Frisoni G; Visser PJ; Barkhof F
    Alzheimers Res Ther; 2018 Sep; 10(1):100. PubMed ID: 30261928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort.
    Liu P; Wu L; Peng G; Han Y; Tang R; Ge J; Zhang L; Jia L; Yue S; Zhou K; Li L; Luo B; Wang B
    Brain Behav Immun; 2019 Aug; 80():633-643. PubMed ID: 31063846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of hippocampal volume and cognitive performances in patients with either mild cognitive impairment or Alzheimer's disease.
    Peng GP; Feng Z; He FP; Chen ZQ; Liu XY; Liu P; Luo BY
    CNS Neurosci Ther; 2015 Jan; 21(1):15-22. PubMed ID: 25146658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET.
    Stonnington CM; Chen Y; Savage CR; Lee W; Bauer RJ; Sharieff S; Thiyyagura P; Alexander GE; Caselli RJ; Locke DEC; Reiman EM; Chen K
    J Alzheimers Dis; 2018; 63(2):603-615. PubMed ID: 29630550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diffusion tensor imaging measures of normal appearing white matter in patients who are aging, or have amnestic mild cognitive impairment, or Alzheimer's disease.
    Wang JH; Lv PY; Wang HB; Li ZL; Li N; Sun ZY; Zhao BH; Huang Y
    J Clin Neurosci; 2013 Aug; 20(8):1089-94. PubMed ID: 23787190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. White matter integrity disruption in the pre-dementia stages of Alzheimer's disease: from subjective memory impairment to amnestic mild cognitive impairment.
    Shao W; Li X; Zhang J; Yang C; Tao W; Zhang S; Zhang Z; Peng D
    Eur J Neurol; 2019 May; 26(5):800-807. PubMed ID: 30584694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of APOE epsilon 2 on intrinsic functional connectivity of the entorhinal cortex is associated with better episodic memory in elderly individuals with risk factors for Alzheimer's disease.
    Chen J; Shu H; Wang Z; Liu D; Shi Y; Xu L; Zhang Z
    Oncotarget; 2016 Sep; 7(37):58789-58801. PubMed ID: 27542235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOE-ε4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies.
    Saeed U; Mirza SS; MacIntosh BJ; Herrmann N; Keith J; Ramirez J; Nestor SM; Yu Q; Knight J; Swardfager W; Potkin SG; Rogaeva E; St George-Hyslop P; Black SE; Masellis M
    Alzheimers Dement; 2018 Sep; 14(9):1137-1147. PubMed ID: 29782824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
    Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D;
    Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.